Work

Protocol for a Randomized Phase II/III Double-Blind Placebo-Controlled Trial to Evaluate the Safety and Efficacy of Extended-Release Metformin in Amnestic Mild Cognitive Impairment

Year: 2025

Type: article

Study design: Study Protocol

Source: Alzheimer Disease & Associated Disorders

DOI: 10.1097/wad.0000000000000677

Authors: José A. Luchsinger, Davangere Devanand, Terry E. Goldberg, Sam Cammack, Gabriela Hernández-Santiago, Kenichi Oishi, William Jagust, Suzanne Baker, Susan Landau, Gayane Yenokyan, Joshua Betz, Stephanie Mayers, Lindsay M. Eyzaguirre, Daniel Hanley, for the MAP Study Group

Institutions: Columbia University Irving Medical Center, Johns Hopkins University, Johns Hopkins Medicine, University of California, Berkeley, Vanderbilt University

Language: English

Topic: Dementia and Cognitive Impairment Research

Subfield: Psychiatry and Mental health

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: closed

OpenAlex ID: W4410822338

FWCI: 10.17

Cites: 28

Cited by: 16

Related to: 10